Skip to main content
. 2014 Mar;58(3):1365–1371. doi: 10.1128/AAC.02161-13

FIG 1.

FIG 1

Serum concentration-time profile after human simulated plasma doses of 2 g ceftazidime–0.5 g avibactam every 8 h as a 2-h infusion in humans compared with that observed in infected female ICR mice.